Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients

The catechol-O-methyltransferase inhibitors entacapone and opicapone prolong the efficacy of conventional oral levodopa/dopa decarboxylase inhibitor formulations through an increase in levodopa plasma bioavailability. Catechol-O-methyltransferase inhibitors influence the homocysteine metabolism asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Thomas, Schlegel, Eugen, Zingler, Stephanie, Thiede, Hans Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105632/
https://www.ncbi.nlm.nih.gov/pubmed/35563817
http://dx.doi.org/10.3390/cells11091511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105632/
https://www.ncbi.nlm.nih.gov/pubmed/35563817
http://dx.doi.org/10.3390/cells11091511

Ejemplares similares